Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Lima Barros Costa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Hospice & Palliative Care|February 21, 2009
Targeted therapy: comprehensive reviewRicardo Lima Barros Costa
Oncotarget|November 29, 2017
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancerJose Mauricio Mota, Katharine Ann Collier, Ricardo Lima Barros Costa, et al.
Breast (Edinburgh, Scotland)|December 1, 2024
Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysisMaria Inez Dacoregio, Isabella Michelon, Caio Ernesto do Rego Castro, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Toxicity profile and tolerability of immune checkpoint inhibitors for the treatment of early-stage breast cancer: a systematic review and meta-analysisMaria Inez Dacoregio, Caio Ernesto do Rego Castro, Isadora Mamede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast CancerGiovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Hospice & Palliative Care|February 21, 2009
Targeted therapy: comprehensive reviewRicardo Lima Barros Costa
Oncotarget|November 29, 2017
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancerJose Mauricio Mota, Katharine Ann Collier, Ricardo Lima Barros Costa, et al.
Breast (Edinburgh, Scotland)|December 1, 2024
Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysisMaria Inez Dacoregio, Isabella Michelon, Caio Ernesto do Rego Castro, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Toxicity profile and tolerability of immune checkpoint inhibitors for the treatment of early-stage breast cancer: a systematic review and meta-analysisMaria Inez Dacoregio, Caio Ernesto do Rego Castro, Isadora Mamede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast CancerGiovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Pageof 1